从非编码RNA的角度来解码肝癌发生
Mostafa K Abd El-Aziz1,2, Alyaa Dawoud3, Caroline J Kiriacos3
1Biochemistry Department, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.
Journal of cellular physiology
|July 14, 2023
概括
长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs) 越来越多地与肝细胞癌 (HCC) 的发展有关. 了解它们的作用为HCC诊断,预后和药物开发提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肝细胞癌 (HCC) 是一种主要的全球性癌症,肝脏瘤发生机制尚不清楚.
- 虽然研究了microRNAs,但长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs) 在HCC中的作用仍未得到研究.
- lncRNAs调节各种细胞功能,它们的失调与HCC的各种病因有关.
研究的目的:
- 审查最近在HCC病理生理学中关于lncRNA和circRNA失调的发现.
- 探索lncRNAs和circRNAs作为HCC新型诊断和预后生物标志物的潜力.
- 讨论未来的趋势和针对HCC中的lncRNAs和circRNAs的治疗策略.
主要方法:
- 关于最近有关HCC的lncRNA和circRNA研究突破的文献综述.
- 对lncRNAs和circRNAs在HCC进展中的病理作用的分析.
- 基于lncRNA和circRNA目标的潜在药物开发策略的讨论.
主要成果:
- lncRNAs和circRNAs在HCC病理生理学中起着重要作用.
- 失调的lncRNAs和circRNAs显示出作为诊断和预后生物标志物的前景.
- 这些非编码RNAs影响HCC的增殖,迁移和上皮细胞到介质细胞的过渡.
结论:
- lncRNAs和circRNAs代表了理解HCC的关键研究领域.
- 准lncRNAs和circRNAs有可能用于新的HCC诊断,预后和治疗应用.
- 对lncRNAs和circRNAs的进一步研究可以推动有效的HCC药物开发.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.9K
11:11Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
8.1K
相关概念视频
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Types of RNA
5.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.9K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
